Classes
Publications
- The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: An analysis of 96 allografted AML patients >= 50 years from the Czech acute leukaemia clinical register (alert)2013 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Medicine in Pilsen
- Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications2013 | Third Faculty of Medicine, Faculty of Medicine in Pilsen
- Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 - a report from the population-based CAMELIA registry2011 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Treatment of patients with relapsed/refractory Hodgkin lymphoma2011 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Therapy of acute promyelocytic leukemia in Czechia: Results and analysis of prognostic factors2008 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Prognostic impact of bone involvement in Hodgkin lymphoma2008 | First Faculty of Medicine, Third Faculty of Medicine
- Impaired intestinal resorption caused by cytostatic treatment - Effect of parenteral glutamine and the preparatory regime2002 | First Faculty of Medicine, Third Faculty of Medicine
- Effect of parenteral glutamine on the restoration of the lymphocytes sub-population after high-dosage chemotherapy with autologous transplantation of haemotopoietic cells: Data from a double blind randomized study2002 | First Faculty of Medicine, Third Faculty of Medicine
- Indications for allogenous and autologous transplantations of blood and bone marrow1997 | First Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine
- Chemobrain in blood cancers: How chemotherapeutics interfere with the brain's structure and functionality, immune system, and metabolic functions2024 | Third Faculty of Medicine, Central Library of Charles University
Loading network view...
